New Kodak Moments Software Helps Retailers Grow Revenue with Advanced Cross-Selling Tools
12.11.2024 13:00:00 CET | Business Wire | Press release
Kodak Moments has released a new version of its photo services software, providing retailers with an easy-to-configure platform to offer consumers more premium products than ever before. As retailers prepare for the pivotal holiday season, cross-selling (the ability to offer consumers additional products that complement their original purchase) can unlock significant revenue potential and enhance the customer experience.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241008507014/en/
Retailers can use cross-selling to offer consumers additional products that complement their original purchase. (Photo: Business Wire)
According to McKinsey, cross-selling can increase sales by 20% and profits by 30%. “Retailers using our latest software releases are reporting significant revenue growth in the photo category,” said Scott Robinson, Kodak Moments VP, Retail Photo Solutions Products. “Much of this is driven by the advanced cross-selling capabilities of our software. It's a significant revenue generator because retailers simply choose the products to cross-sell, and the software takes care of the rest. It automatically suggests complementary products to consumers at just the right points during their shopping journey.” For instance, when a consumer uploads a photo, they can be shown how it looks on a canvas, panel, mug, or a selection of other products, providing a seamless ordering experience that maximizes sales potential.
Retailers now have 39 premium photo products that can be configured as cross-sells on the Kodak Moments platform. Kodak Moments Retail Software version 24.2 is compatible with Kodak Moments Kiosks, Kodak Moments Self-Service Print Stations, and the Kodak Moments Adaptive Picture Exchange (APEX) dry lab solution. Version 24.2 combines previous releases that, in total, deliver more than 70 new features and upgrades designed to maximize retailers’ ability to provide consumers with premium photo products and services.
Photo Drinkware and Coaster Expansion
Kodak Moments Retail Software v24.2 increases retailers’ capacity to produce personalized drinkware for same-day purchase. The latest release includes a new stainless-steel tumbler available just in time for the holidays.
Retailers can also offer a new 11-ounce heat-activated photo mug, also known as a “magic mug.” Consumers can upload images directly from their device or cloud storage service and design their mug online, or touch-free in store. When consumers fill their mug with a hot drink, their photo appears. “This unique mug is a picture-perfect addition to the morning routine and a thoughtful photo gift for any occasion,” said Robinson.
Custom photo mugs are available in several sizes and styles, providing options to suit any beverage or occasion.
To complement the new drinkware products, retailers can now offer customized photo coasters — a favorite for weddings, retirements, birthday parties, and everyday use. The same-day product is printed in store and presents an excellent cross-selling opportunity when paired with drinkware purchases.
Optimizing the Retailer and Consumer Experience
Kodak Moments software integrates with existing hardware and can be configured to match retailers’ order fulfillment capabilities including delivery to home, order online for pickup in store, and more. Kodak Moments’ newest instore offering, the Self-Service Print Station, allows consumers to create, order, pay, and collect their prints immediately, freeing store clerks to concentrate on premium products and other store activities. All of these features and benefits are designed to help retailers provide a better consumer experience and reduce labor costs, especially in high-volume stores.
“We are constantly simplifying and improving ways for retailers to deliver same-day premium photo products to consumers,” said Robinson.
About Kodak Moments
Kodak Moments is a leading global provider of photo products and services to retailers, consumers, and entertainment properties. We inspire consumers to bring their memories to life—delivering innovative, high-quality photo products and experiences they find truly meaningful. Powered by over 100,000 consumer touchpoints across 30 countries globally, it’s our mission to be the brand consumers choose to celebrate and preserve life’s memories, from the big events to the everyday moments that matter. For more information, please visit Kodak Moments and follow Kodak Moments on LinkedIn.
© 2024 Kodak Moments Division, Kodak Alaris Inc.
The Kodak trademark and trade dress are used under license from Eastman Kodak Company.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241008507014/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release
Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom